Surgical Sealants and Adhesives Global Market – Forecast To 2024
| Publishing Date : | March, 2018 |
| Report Code : | HCMD0156 |
| Price: |
Single license $4,950
Site license $6,750 Global license $9,000 |
Note: The report would be dispatched after confirmation of payment
Surgical sealants and adhesives are the products used to close the surgical incisions, post surgical application, block the passage of fluids through the surface or openings of the wounds and also to avoid the microbial adhesions and infections. Sealants and Adhesives are usually considered together as they both adhere and seal the surgical incisions. According to IQ4I analysis, the surgical sealants and adhesives global market is expected to grow at a strong CAGR to reach $3,708.5 million by 2024.
The surgical sealants and adhesives global market is mainly segmented by products, applications, end-users and by geography. The surgical sealants and adhesives global market by the product is segmented into natural and synthetic surgical sealants and adhesives. Natural surgical sealants and adhesives are segmented into fibrin, collagen, gelatin, albumin and others. Synthetic surgical sealants and adhesives are segmented into Cyanoacrylate, hydrogels and others. The application market is segmented into Cardiovascular surgery, General Surgery, Orthopaedic surgery, Urology, Pulmonology, Neurosurgery, Gynecology, Cosmetic surgery and Others applications. The end-users market is segmented into hospitals, ambulatory surgical centres and others.
Some of the major players in Surgical sealants and adhesives market include Baxter International Inc. (U.S.), Johnson & Johnson (Ethicon) (U.S.), Becton, Dickinson & Company (C.R.Bard) (U.S.), B.Braun Melsungen AG (Germany), Medtronic Plc (Ireland), Cryolife, Inc. (U.S.), Mallinckrodt Plc (U.K.), Advanced Medical Solutions Group Plc (U.K.), Takeda Pharmaceutical Company Ltd. (Japan), Cohera Medical, Inc. (U.S.).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
- North America
- U.S.
- Others
- Europe
- Germany
- U.K.
- France
- Others
- Asia-Pacific
- Japan
- China
- India
- Others
- Rest of the World (RoW)
- Brazil
- Rest of Latin America
- Middle East & Others
- 1 EXECUTIVE SUMMARY
- 2 INTRODUCTION
- 2.1 KEY TAKEAWAYS
- 2.2 SCOPE OF THE REPORT
- 2.3 REPORT DESCRIPTION
- 2.4 MARKETS COVERED
- 2.5 STAKEHOLDERS
- 2.6 RESEARCH METHODOLOGY
- 2.6.1 MARKET SIZE ESTIMATION
- 2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
- 2.6.3 SECONDARY SOURCES
- 2.6.4 PRIMARY SOURCES
- 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
- 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
- 2.6.7 ASSUMPTIONS
- 3 MARKET ANALYSIS
- 3.1 INTRODUCTION
- 3.2 MARKET SEGMENTATION
- 3.3 FACTORS INFLUENCING MARKET
- 3.3.1 DRIVERS AND OPPORTUNITIES
- 3.3.1.1 INCREASING DEMAND FOR SURGICAL PROCEDURES BOOSTS SURGICAL SEALANTS AND ADHESIVES MARKET GROWTH
- 3.3.1.2 EMERGENCE OF TECHNICALLY ADVANCED PRODUCTS
- 3.3.1.3 ACQUISITION TO OPEN AN ARRAY OF OPPORTUNITIES FOR THE MARKET TO FLOURISH
- 3.3.1.4 INCREASING GERIATRIC POPULATION
- 3.3.1.5 ACCEPTANCE OF SURGICAL SEALANTS AND ADHESIVES AND MARKET EXPANSION IN EMERGING NATIONS
- 3.3.2 RESTRAINTS AND THREATS
- 3.3.2.1 PITFALLS IN USAGE OF SURGICAL SEALANTS AND ADHESIVES
- 3.3.2.2 EXPENSIVE SURGICAL SEALANTS AND ADHESIVES IMPEDING EFFECTIVE PENETRATION IN LOW AND MIDDLE INCOME COUNTRIES
- 3.3.2.3 UNFAVORABLE REIMBURSEMENT POLICIES IN DEVELOPING NATIONS
- 3.3.2.4 STRINGENT REGULATORY GUIDELINES
- 3.3.2.5 AVAILABILITY OF ALTERNATIVE PRODUCTS
- 3.4 REGULATORY AFFAIRS
- 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
- 3.4.1.1 ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
- 3.4.1.2 ISO 14644-1 CLEAN ROOM STANDARDS
- 3.4.1.3 ISO 13485 MEDICAL DEVICES
- 3.4.1.4 ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
- 3.4.2 ASTM INTERNATIONAL STANDARDS
- 3.4.3 U.S.
- 3.4.4 CANADA
- 3.4.5 EUROPE
- 3.4.6 JAPAN
- 3.4.7 CHINA
- 3.4.8 INDIA
- 3.5 CLINICAL TRIALS
- 3.6 PORTER’S FIVE FORCE ANALYSIS
- 3.6.1 THREAT OF NEW ENTRANTS
- 3.6.2 THREAT OF SUBSTITUTES
- 3.6.3 BARGAINING POWER OF SUPPLIERS
- 3.6.4 BARGAINING POWER OF BUYERS
- 3.6.5 RIVALRY AMONG EXISTING COMPETITORS
- 3.7 SUPPLY CHAIN ANALYSIS
- 3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
- 3.9 SURGICAL SEALANTS AND ADHESIVES COMPANY COMPARISON BY PRODUCT TYPE, MATERIAL, PRODUCT NAME AND APPLICATIONS
- 3.10 MARKET PENETRATION OF SURGICAL SEALANTS AND ADHESIVES IN SURGICAL WOUND CLOSURE MARKET
- 4 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET, BY PRODUCT
- 4.1 INTRODUCTION
- 4.2 NATURAL SURGICAL SEALANTS AND ADHESIVES
- 4.2.1 FIBRIN
- 4.2.2 COLLAGEN
- 4.2.3 GELATIN
- 4.2.4 ALBUMIN
- 4.2.5 OTHERS
- 4.3 SYNTHETIC SURGICAL SEALANTS AND ADHESIVES
- 4.3.1 CYANOACRYLATE
- 4.3.2 HYDROGEL
- 4.3.3 OTHERS
- 5 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET, BY APPLICATION
- 5.1 INTRODUCTION
- 5.2 CARDIOVASCULAR SURGERY
- 5.3 GENERAL SURGERY
- 5.4 ORTHOPAEDIC SURGERY
- 5.5 UROLOGY
- 5.6 PULMONOLOGY
- 5.7 NEUROSURGERY
- 5.8 GYNAECOLOGY
- 5.9 COSMETIC SURGERY
- 5.10 OTHERS
- 6 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET, BY END-USERS
- 6.1 INTRODUCTION
- 6.2 HOSPITALS
- 6.3 AMBULATORY SURGICAL CENTERS
- 6.4 OTHERS
- 7 REGIONAL ANALYSIS
- 7.1 INTRODUCTION
- 7.2 NORTH AMERICA
- 7.2.1 U.S.
- 7.2.2 OTHERS
- 7.3 EUROPE
- 7.3.1 GERMANY
- 7.3.2 U.K.
- 7.3.3 FRANCE
- 7.3.4 OTHERS
- 7.4 APAC
- 7.4.1 JAPAN
- 7.4.2 CHINA
- 7.4.3 INDIA
- 7.4.4 OTHERS
- 7.5 ROW
- 7.5.1 BRAZIL
- 7.5.2 REST OF LATIN AMERICA
- 7.5.3 MIDDLE EAST AND OTHERS
- 8 COMPETITIVE LANDSCAPE
- 8.1 INTRODUCTION
- 8.2 APPROVALS
- 8.3 AGREEMENT
- 8.4 ACQUISITIONS
- 8.5 NEW PRODUCT LAUNCH
- 8.6 OTHER DEVELOPMENTS
- 9 MAJOR COMPANIES
- 9.1 ADVANCED MEDICAL SOLUTIONS GROUP PLC
- 9.1.1 OVERVIEW
- 9.1.2 FINANCIALS
- 9.1.3 PRODUCT PORTFOLIO
- 9.1.4 KEY DEVELOPMENTS
- 9.1.5 BUSINESS STRATEGY
- 9.1.6 SWOT ANALYSIS
- 9.2 BAXTER INTERNATIONAL, INC
- 9.2.1 OVERVIEW
- 9.2.2 FINANCIALS
- 9.2.3 PRODUCT PORTFOLIO
- 9.2.4 KEY DEVELOPMENTS
- 9.2.5 BUSINESS STRATEGY
- 9.2.6 SWOT ANALYSIS
- 9.3 B.BRAUN MELSUNGEN AG
- 9.3.1 OVERVIEW
- 9.3.2 FINANCIALS
- 9.3.3 PRODUCT PORTFOLIO
- 9.3.4 KEY DEVELOPMENTS
- 9.3.5 BUSINESS STRATEGY
- 9.3.6 SWOT ANALYSIS
- 9.4 BECTON, DICKINSON AND COMPANY (C.R.BARD INC.)
- 9.4.1 OVERVIEW
- 9.4.2 FINANCIALS*
- 9.4.3 PRODUCT PORTFOLIO
- 9.4.4 KEY DEVELOPMENTS
- 9.4.5 BUSINESS STRATEGY
- 9.4.6 SWOT ANALYSIS
- 9.5 COHERA MEDICAL, INC.
- 9.5.1 OVERVIEW
- 9.5.2 FINANCIALS
- 9.5.3 PRODUCT PORTFOLIO
- 9.5.4 KEY DEVELOPMENTS
- 9.5.5 BUSINESS STRATEGY
- 9.5.6 SWOT ANALYSIS
- 9.6 CRYOLIFE, INC.
- 9.6.1 OVERVIEW
- 9.6.2 FINANCIALS
- 9.6.3 PRODUCT PORTFOLIO
- 9.6.4 KEY DEVELOPMENTS
- 9.6.5 BUSINESS STRATEGY
- 9.6.6 SWOT ANALYSIS
- 9.7 JOHNSON & JOHNSON (ETHICON)
- 9.7.1 OVERVIEW
- 9.7.2 FINANCIALS
- 9.7.3 PRODUCT PORTFOLIO
- 9.7.4 KEY DEVELOPMENTS
- 9.7.5 BUSINESS STRATEGY
- 9.7.6 SWOT ANALYSIS
- 9.8 MALLINCKRODT PLC
- 9.8.1 OVERVIEW
- 9.8.2 FINANCIALS
- 9.8.3 PRODUCT PORTFOLIO
- 9.8.4 KEY DEVELOPMENTS
- 9.8.5 BUSINESS STRATEGY
- 9.8.6 SWOT ANALYSIS
- 9.9 MEDTRONIC PLC
- 9.9.1 OVERVIEW
- 9.9.2 FINANCIALS
- 9.9.3 PRODUCT PORTFOLIO
- 9.9.4 KEY DEVELOPMENTS
- 9.9.5 BUSINESS STRATEGY
- 9.9.6 SWOT ANALYSIS
- 9.10 TAKEDA PHARMACEUTICAL COMPANY LTD.
- 9.10.1 OVERVIEW
- 9.10.2 FINANCIALS
- 9.10.3 PRODUCT PORTFOLIO
- 9.10.4 KEY DEVELOPMENTS
- 9.10.5 BUSINESS STRATEGY
- 9.10.6 SWOT ANALYSIS
- TABLE 1 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 2 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 3 NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 4 NATURALSURGICALSEALANTSANDADHESIVESGLOBALMARKETREVENUE, BYREGION, (2016-2024)($MN)
- TABLE 5 FIBRIN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 6 COLLAGEN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 7 GELATIN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 8 ALBUMIN GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 9 OTHERNATURALSURGICALSEALANTSANDADHESIVESGLOBALMARKETREVENUE,BYREGION,(2016-2024)($MN)
- TABLE 10 SYNTHETICSURGICALSEALANTSANDADHESIVESGLOBALMARKETREVENUE,BYPRODUCT,(2016-2024)($MN)
- TABLE 11 SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 12 CYANOACRYLATE GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 13 HYDROGEL GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 14 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 15 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
- TABLE 16 CARDIOVASCULAR SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 17 GENERAL SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 18 ORTHOPAEDIC SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 19 UROLOGY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 20 PULMONOLOGY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 21 NEUROSURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 22 GYNAECOLOGY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 23 COSMETIC SURGERY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 24 OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 25 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
- TABLE 26 HOSPITALS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 27 AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 28 OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 29 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
- TABLE 30 NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 31 NORTH AMERICA NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 32 NORTH AMERICA SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 33 NORTH AMERICAN SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
- TABLE 34 NORTH AMERICAN SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN)
- TABLE 35 NORTH AMERICAN SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
- TABLE 36 EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 37 EUROPE NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 38 EUROPE SYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 39 EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
- TABLE 40 EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN)
- TABLE 41 EUROPE SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
- TABLE 42 APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 43 APAC NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 44 APAC SYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 45 APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
- TABLE 46 APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN)
- TABLE 47 APAC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
- TABLE 48 ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN)
- TABLE 49 ROW NATURAL SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 50 ROW SYNTHETIC SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY PRODUCT, (2016-2024) ($MN)
- TABLE 51 ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
- TABLE 52 ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY END-USER, (2016-2024) ($MN)
- TABLE 53 ROW SURGICAL SEALANTS AND ADHESIVES MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
- TABLE 54 APPROVALS (2015 - 2018)
- TABLE 55 AGREEMENT (2015 - 2018)
- TABLE 56 ACQUISITIONS (2015 - 2018)
- TABLE 57 NEW PRODUCT LAUNCH (2015 - 2018)
- TABLE 58 OTHER DEVELOPMENTS (2015 - 2018)
- TABLE 59 ADVANCED MEDICAL SOLUTIONS GROUP PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 60 ADVANCED MEDICAL SOLUTIONS GROUP PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
- TABLE 61 ADVANCED MEDICAL SOLUTIONS GROUP PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
- TABLE 62 BAXTER INTERNATIONAL, INC.: TOTAL SALES AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 63 BAXTER INTERNATIONAL, INC.: TOTAL SALES, BY SEGMENTS, (2015-2017) ($MN)
- TABLE 64 BAXTER INTERNATIONAL, INC.: TOTAL SALES, BY GEOGRAPHY, (2015-2017) ($MN)
- TABLE 65 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
- TABLE 66 B.BRAUN MELSENGEN AG: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
- TABLE 67 B.BRAUN MELSENGEN, AG: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
- TABLE 68 C.R.BARD INC.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 69 C.R.BARD INC: TOTAL REVENUE BY SEGMENTS, (2015-17) ($MN)
- TABLE 70 C.R. BARD: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
- TABLE 71 CRYOLIFE, INC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 72 CRYOLIFE, INC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
- TABLE 73 CRYOLIFE, INC: TOTAL REVENUE, BY PRODUCTS, (2015-2017) ($MN)
- TABLE 74 CRYOLIFE, INC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
- TABLE 75 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 76 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
- TABLE 77 JOHNSON & JOHNSON: TOTAL REVENUE, BY MEDICAL DEVICES SEGMENTS, (2015-2017) ($MN)
- TABLE 78 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
- TABLE 79 MALLINCKRODT PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 80 MALLINCKRODT PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
- TABLE 81 MALLINCKRODT PLC: TOTAL REVENUE, BY SUB-SEGMENTS, (2015-2017) ($MN)
- TABLE 82 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- TABLE 83 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
- TABLE 84 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
- TABLE 85 TAKEDA PHARMACEUTICAL COMPANY LTD: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
- FIGURE 1 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
- FIGURE 2 RESEARCH METHODOLOGY: SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET
- FIGURE 3 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
- FIGURE 4 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: FORECASTING MODEL
- FIGURE 5 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
- FIGURE 6 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SEGMENTATION
- FIGURE 7 MARKET DYNAMICS
- FIGURE 8 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: PORTER’S ANALYSIS
- FIGURE 9 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 10 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
- FIGURE 11 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET PENETRATION, BY APPLICATION (2017) (%)
- FIGURE 12 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT (2016 - 2024) ($MN)
- FIGURE 13 NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 14 NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 15 FIBRIN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 16 COLLAGEN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 17 GELATIN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 18 ALBUMIN GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 19 OTHER NATURAL SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 20 SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 21 SYNTHETIC SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 22 CYANOACRYLATE GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 23 HYDROGEL GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 24 OTHERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 25 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY APPLICATION, (2017 V/S 2024) ($MN)
- FIGURE 26 CARDIOVASCULAR SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 27 GENERAL SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 28 ORTHOPAEDIC SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 29 UROLOGY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 30 PULMONOLOGY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 31 NEUROSURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 32 GYNAECOLOGY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 33 COSMETIC SURGERY GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 34 OTHER APPLICATIONS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 35 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY END-USERS, (2017 V/S 2024) ($MN)
- FIGURE 36 HOSPITALS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 37 AMBULATORY SURGICAL CENTERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 38 OTHER END-USERS GLOBAL MARKET SHARE, BY REGION, (2017 V/S 2024) (%)
- FIGURE 39 SURGICAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN), CAGR (%)
- FIGURE 40 NORTH AMERICA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 41 NORTH AMERICA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 42 U.S. SURGICAL S & A MARKET REVENUE, BY PRODUCT/END-USER, NATURAL AND SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 43 U.S. SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 44 OTHER NORTH AMERICA COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 45 OTHER NORTH AMERICA COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 46 EUROPE SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 47 EUROPE SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 48 GERMANY SURGICAL S & A REVENUE, BY PRODUCT/END-USER NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 49 GERMANY SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 50 U.K. SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 51 U.K. SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 52 FRANCE SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 53 FRANCE SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 54 OTHER EUROPE COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 55 OTHER EUROPE COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 56 APAC SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 57 APAC SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 58 JAPAN SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 59 JAPAN SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 60 CHINA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 61 CHINA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 62 INDIA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 63 INDIA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 64 OTHER APAC COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 65 OTHER APAC COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 66 ROW SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 67 ROW SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 68 BRAZIL SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 69 BRAZIL SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 70 REST OF LATIN AMERICA SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 71 REST OF LATIN AMERICA SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 72 MIDDLE EAST AND OTHER ROW COUNTRIES SURGICAL S & A REVENUE, BY PRODUCT/END-USER, NATURAL & SYNTHETIC S & A, BY PRODUCT (2017 V/S 2024) ($MN)
- FIGURE 73 MIDDLE EAST AND OTHER ROW COUNTRIES SURGICAL SEALANTS AND ADHESIVES REVENUE, BY APPLICATION (2017 V/S 2024) ($MN)
- FIGURE 74 KEY GROWTH STRATEGIES, (2015-2018)
- FIGURE 75 SWOT: ADVANCED SOLUTIONS GROUP PLC
- FIGURE 76 SWOT: BAXTER INTERNATIONAL, INC.
- FIGURE 77 SWOT: B.BRAUN MELSUNGEN, AG
- FIGURE 78 SWOT: BD (C.R.BARD, INC.)
- FIGURE 79 SWOT: COHERA MEDICAL, INC.
- FIGURE 80 SWOT: CRYOLIFE, INC.
- FIGURE 81 SWOT: JOHNSON & JOHNSON (ETHICON)
- FIGURE 82 SWOT: MALLINCKRODT PLC
- FIGURE 83 SWOT: MEDTRONIC, PLC
- FIGURE 84 SWOT: TAKEDA PHARMACEUTICAL COMPANY LTD.
- 1 ADHEZION BIOMEDICAL, LLC.
- 2 ADVANCED MEDICAL SOLUTIONS GROUP PLC
- 3 ARCH THERAPEUTICS, INC
- 4 B.BRAUN MELSUNGEN AG
- 5 BAXTER INTERNATIONAL, INC.
- 6 BD (C.R. BARD, INC.)
- 7 BEAVER VISITEC INTERNATIONAL
- 8 CARDINALHEALTH, INC
- 9 CHEMENCE MEDICAL, INC.
- 10 COHERA MEDICAL, INC.
- 11 CONNEXICON MEDICAL LTD.
- 12 CRYOLIFE, INC.
- 13 DYNASIL CORPORATION OF AMERICA (XCEDE TECHNOLOGIES, INC.)
- 14 GECKO BIOMEDICAL
- 15 GEM SRL
- 16 GLUSTITCH, INC.
- 17 GRÜNENTHAL GMBH (ADHESYS MEDICAL GMBH)
- 18 HAGER & WERKEN GMBH & CO. KG
- 19 H.B. FULLER
- 20 HALYARD HEALTH, INC.
- 21 HUALAN BIOLOGICAL ENGINEERING
- 22 HYPERBRANCH MEDICAL TECHNOLOGY, INC.
- 23 IBC PHARMACEUTICALS LTD.
- 24 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
- 25 JOHNSON & JOHNSON (ETHICON )
- 26 KUROS BIOSCIENCES AG
- 27 LIFEBOND LTD.
- 28 MALLINCKRODT PLC
- 29 MEDTRONIC PLC
- 30 OCULAR THERAPEUTIX, INC.
- 31 OPTMED, INC.
- 32 RELIANCE LIFE SCIENCE
- 33 SEALANTIS LTD
- 34 STARCH MEDICAL, INC.
- 35 STRYKER CORPORATION
- 36 SURGICAL SPECIALTIES CORPORATION
- 37 TAKEDA PHARMACEUTICAL COMPANY LTD.
- 38 TISSUEMED LTD.
- 39 VIVOSTAT A/S
- 40 WESTERN BIOMEDICAL